Phenylbutazone-d9
Product Specifications
CAS Number
1189479-75-1
Target
COX
Related Pathways
Neuroscience|||Immunology/Inflammation
Bioactivity
Phenylbutazone-d9 is intended for use as an internal standard for the quantification of phenylbutazone by GC- or LC-MS. Phenylbutazone is a non-steroidal anti-inflammatory drug and an inhibitor of the peroxidase activity of COX (IC50 = ~100 µM in the presence of hydrogen peroxide) . It also inhibits prostaglandin I synthase (IC50 = ~25 µM in the presence of hydrogen peroxide) . Phenylbutazone (2 mg/kg) reduces increases in type II collagen levels in the inflamed joints of an equine model of LPS-induced acute synovitis. Formulations containing phenylbutazone have been used in the treatment of lameness in horses.
Smiles
O=C1N(N(C(=O)C1C(C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C19H11D9N2O2
Molecular Weight
317.43
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/87F138F3-9F58-444C-BB88-C4905BE39AB0/T71288
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1026924-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Major fimbrial subunit (hifA)
Ask
View Details